Variant report
Variant | esv3414985 |
---|---|
Chromosome Location | chr3:160601206-160601758 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570883620 | chr3:160601246-160601247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539935131 | chr3:160601286-160601287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553547017 | chr3:160601315-160601316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190103942 | chr3:160601324-160601325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6785844 | chr3:160601327-160601328 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs555951936 | chr3:160601437-160601438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565568667 | chr3:160601469-160601470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575814350 | chr3:160601471-160601472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544924427 | chr3:160601495-160601496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528733772 | chr3:160601589-160601590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs56178934 | chr3:160601598-160601599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182750324 | chr3:160601658-160601659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568658257 | chr3:160601669-160601670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562923118 | chr3:160601676-160601677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs36011243 | chr3:160601688-160601689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544448781 | chr3:160601698-160601699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75621526 | chr3:160601707-160601708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78448608 | chr3:160601708-160601709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187351930 | chr3:160601717-160601718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373845428 | chr3:160601748-160601749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:160595600-160602000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
2 | chr3:160596400-160603800 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
3 | chr3:160597800-160601400 | Weak transcription | Psoas Muscle | Psoas |
4 | chr3:160598000-160603400 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
5 | chr3:160601200-160602000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
6 | chr3:160601400-160601600 | Enhancers | Fetal Thymus | thymus |
7 | chr3:160601400-160601600 | Enhancers | Left Ventricle | heart |
8 | chr3:160601400-160602600 | Enhancers | Psoas Muscle | Psoas |
9 | chr3:160601600-160602200 | Weak transcription | Fetal Thymus | thymus |
10 | chr3:160601600-160603200 | Weak transcription | Left Ventricle | heart |